{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:46:26Z","timestamp":1789677986278,"version":"4.0.1"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamasurg.2021.0254","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T15:32:36Z","timestamp":1617204756000},"page":"541","source":"Crossref","is-referenced-by-count":86,"title":["Outcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary Aldosteronism"],"prefix":"10.1001","volume":"156","author":[{"given":"Yuan-yuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"King","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"},{"name":"Alberta SPOR SUPPORT Unit Data Platform, Alberta Health Services, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Kline","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj S.","family":"Padwal","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Pasieka","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanmin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"So","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Harvey","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Alberta Precision Laboratories, Alberta Health Services, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"},{"name":"Division of Endocrinology & Metabolism, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"soi210008r1","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis.","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"soi210008r2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study.","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"soi210008r3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"soi210008r4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"soi210008r5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment.","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"soi210008r6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Horm Metab Res"},{"issue":"8","key":"soi210008r7","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1097\/HJH.0000000000001384","article-title":"Diagnostic rate of primary aldosteronism in Emilia-Romagna, northern Italy, during 16 years (2000-2015).","volume":"35","author":"Rossi","year":"2017","journal-title":"J Hypertens"},{"issue":"5","key":"soi210008r8","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline.","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"soi210008r9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cjca.2017.03.005","article-title":"Hypertension Canada\u2019s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults.","volume":"33","author":"Leung","year":"2017","journal-title":"Can J Cardiol"},{"issue":"12","key":"soi210008r10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S2213-8587(16)30272-8","article-title":"Primary aldosteronism as a public health issue.","volume":"4","author":"Funder","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"soi210008r11","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe.","volume":"34","author":"Mulatero","year":"2016","journal-title":"J Hypertens"},{"issue":"10","key":"soi210008r12","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1210\/jc.2012-3046","article-title":"Primary aldosteronism: clinical lateralization and costs.","volume":"97","author":"Funder","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"soi210008r13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","article-title":"Screening rates for primary aldosteronism in resistant hypertension: a cohort study.","volume":"75","author":"Jaffe","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"soi210008r14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/HYPERTENSIONAHA.115.05702","article-title":"Healthcare costs attributable to hypertension: Canadian population-based cohort study.","volume":"66","author":"Weaver","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"soi210008r15","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1161\/HYPERTENSIONAHA.109.139279","article-title":"Validation of a case definition to define hypertension using administrative data.","volume":"54","author":"Quan","year":"2009","journal-title":"Hypertension"},{"issue":"10","key":"soi210008r16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/heartjnl-2012-303152","article-title":"Incidence, cardiovascular complications and mortality of hypertension by sex and ethnicity.","volume":"99","author":"Quan","year":"2013","journal-title":"Heart"},{"issue":"22","key":"soi210008r17","doi-asserted-by":"publisher","first-page":"E773","DOI":"10.1503\/cmaj.161486","article-title":"Primary aldosteronism: a common cause of resistant hypertension.","volume":"189","author":"Kline","year":"2017","journal-title":"CMAJ"},{"issue":"3","key":"soi210008r18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/HYPERTENSIONAHA.116.08407","article-title":"Novel approach to establishing an aldosterone: renin ratio cutoff for primary aldosteronism.","volume":"69","author":"Leung","year":"2017","journal-title":"Hypertension"},{"issue":"5","key":"soi210008r19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome.","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch Surg"},{"issue":"2","key":"soi210008r20","first-page":"3","article-title":"Risk factors for hypertension in Canada.","volume":"30","author":"Leung","year":"2019","journal-title":"Health Rep"},{"issue":"5","key":"soi210008r21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cjca.2020.02.092","article-title":"Worsening hypertension awareness, treatment, and control rates in Canadian women between 2007 and 2017.","volume":"36","author":"Leung","year":"2020","journal-title":"Can J Cardiol"},{"issue":"7","key":"soi210008r23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/jch.12342","article-title":"High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses.","volume":"16","author":"Kline","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"soi210008r24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-042711-135929","article-title":"Hyperaldosteronism as a common cause of resistant hypertension.","volume":"64","author":"Calhoun","year":"2013","journal-title":"Annu Rev Med"},{"issue":"4","key":"soi210008r25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit.","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"soi210008r26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.surg.2018.05.085","article-title":"Keeping primary aldosteronism in mind: deficiencies in screening at-risk hypertensives.","volume":"165","author":"Ruhle","year":"2019","journal-title":"Surgery"},{"issue":"8","key":"soi210008r27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S2213-8587(18)30174-8","article-title":"Investigation of primary aldosteronism in patients with resistant hypertension\u2014authors\u2019 reply.","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"soi210008r28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11154-011-9157-5","article-title":"Primary aldosteronism and a Texas two-step.","volume":"12","author":"Auchus","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"soi210008r29","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1097\/HJH.0b013e328356c5be","article-title":"Ultimately we are in furious agreement.","volume":"30","author":"Funder","year":"2012","journal-title":"J Hypertens"},{"issue":"6","key":"soi210008r30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cen.2015.82.issue-6","article-title":"Primary aldosteronism: unnecessary complexity in definition and diagnosis as a barrier to wider clinical care.","volume":"82","author":"Kline","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"soi210008r31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7326\/M20-1758","article-title":"Primary aldosteronism: at the tipping point.","volume":"173","author":"Funder","year":"2020","journal-title":"Ann Intern Med"},{"key":"soi210008r32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/bs.vh.2018.10.006","article-title":"Primary aldosteronism: present and future.","volume":"109","author":"Funder","year":"2019","journal-title":"Vitam Horm"},{"issue":"8","key":"soi210008r33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism.","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"1","key":"soi210008r34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"soi210008r35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis.","volume":"48","author":"Rehan","year":"2015","journal-title":"Clin Biochem"},{"issue":"7","key":"soi210008r36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jch.12523","article-title":"Unadjusted plasma renin activity as a \u201cfirst-look\u201d test to decide upon further investigations for primary aldosteronism.","volume":"17","author":"Rye","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10008","key":"soi210008r37","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"soi210008r38","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among us adults with hypertension, 1999-2000 to 2017-2018.","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"key":"soi210008r22","unstructured":"Alberta Health Services. AHS map and zone overview. Published 2017. Accessed December 15, 2020. https:\/\/www.albertahealthservices.ca\/assets\/about\/publications\/ahs-ar-2017\/zones.html"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2777912\/jamasurgery_liu_2021_oi_210008_1622842087.19822.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:38:18Z","timestamp":1623253098000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2777912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2021.0254","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}